The Globe and Mail reports in its Tuesday edition that Auxly Cannabis Group ranks high in key three areas -- price-to-earnings, insider commitment and the stock's relative price momentum. Guest columnist Ted Dixon writes the stock is trading at a 12-month P/E of about 9.2, well below the Canadian market average of 17.8. Meanwhile, chief executive officer Hugo Alves spent just over a quarter of a million dollars buying shares in the public market over the past six months. His most recent purchase was 440,000 shares at 17 cents on Aug. 19. Independent director Conrad Tate bought 485,000 shares at the same price on the same day. The insider buying has been taking place despite the stock rising 282.5 per cent in the first eight months of the year. Auxly is focused on the Canadian market. In the second quarter, net revenues were $38.8-million, up 33 per cent year-over-year. Mr. Alves attributed the growth to "increased demand for our products, deeper distribution across the country, increasing production volumes and higher pricing." Mr. Dixon says it is always encouraging when a CEO reinforces their upbeat words with public market buying.